Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
about
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib.ALK Protein Expression is Related to Neuroblastoma Aggressiveness, But is Not Independent Prognostic Factor.PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcoma.Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and Adolescents.
P2860
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@en
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@nl
type
label
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@en
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@nl
prefLabel
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@en
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Anaplastic lymphoma kinase abe ...... in pediatric rhabdomyosarcoma
@en
P2093
Angelica Zin
Cristina R Antonescu
Luca Bergamaschi
Paolo Bonvini
Raffaella Villa
Renata Boldrini
Rita Alaggio
Roberto Caserini
Roberto Luksch
P2860
P304
58903-58914
P356
10.18632/ONCOTARGET.10368
P407
P50
P577
2016-09-01T00:00:00Z